EU Regulator To Re-Examine Safety Of Common Drugs

Law360, New York (September 26, 2006, 12:00 AM EDT) -- Europe’s top drug agency has launched another review of commonly used anti-inflammatory drugs amid concerns over a link to heightened risk of heart attacks.

The European Medicines Agency (EMA) said on Tuesday that it was launching a new review on non-selective non-steroidal anti-inflammatory drugs (NSAIDs), reversing an earlier stance that gave NSAIDs a clean bill of health.

EMA will present a scientific opinion next month to address the benefit-risk profile of the drugs, the agency said.

NSAIDs are widely used to treat arthritis and other painful...
To view the full article, register now.